Why the Zoono share price rocketed another 19% higher today

Here's why the Zoono Group Ltd (ASX: ZNO) share price has rocketed another 19.26% today to close at $2.26.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Zoono Group Ltd (ASX: ZNO) share price rocketed another 19.26% today to close at $2.26. This follows what appears to be further positive upwards market momentum following two ASX announcements made last Friday.

The first announcement was regarding successful test results for Zoono's products against COVID-19, while the second announcement relates to an update on its distribution agreement with Eagle Health Holdings Ltd (ASX: EHH).

Zoono is a global biotech company that specialises in the development, manufacture and global distribution of antimicrobial solutions.

Since 10 January, the Zoono share price has rocketed upward from $0.56 to reach today's closing price of $2.26, a massive 304% gain. In the last 3 days of trading (including today), Zoono shares have shot up 66% from last Wednesday's closing price of $1.36.

Zoono product >99.99% effective against coronavirus

In an ASX announcement last Friday morning, Zoono revealed it had received a report for laboratory tests undertaken against COVID-19.

According to Zoono, the results indicated that Zoono's Z-71 Microbe Shield is more than 99.99% effective against COVID-19. This microbe shield is the same Zoono technology used in its Zoono hand-sanitiser.

The company confirmed to the market that its products had been successfully tested against a variety of pathogens for periods of up to 30 days on surfaces and for 24 hours on hands.

The company added that this recent test further demonstrates the ability of the Zoono technology to be part of the solution to prevent and protect against the spread of the COVID-19 virus.

Update on the agreement with Eagle

In a second announcement to the market last Friday, Zoono relayed an announcement from Eagle providing an update to the distribution agreement between the two companies.

Eagle is a health and nutritional products business that develops, manufactures and distributes products into 26 provinces in China.

Under the agreement, Zoono and Eagle have a 'co-branding' arrangement through which Eagle will import Zoono's formulations in bulk to Eagle's wholly-owned good manufacturing practice (GMP) certified pharmaceutical facility in Xiamen China. At this facility, Eagle will carry out the labelling, packaging and distribution of Zoono's formulations into Eagle's existing channels.

On Friday, Eagle announced it was awaiting the final inspection of its GMP pharmaceutical facilities by the Xiamen's local government. This was in regard to the additional licenses required by Eagle to facilitate the packaging and distribution of Zoono products. This final inspection is currently scheduled for 3 March.

Additionally, Eagle also announced that the first shipment from Zoono, approximately 4 tonnes of product, was being prepared for transport to Xiamen and was scheduled to be despatched from Auckland that very day.

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »

Father in the ocean with his daughters, symbolising passive income.
Dividend Investing

I'd spend $8k on these ASX 200 shares today to target a $6,102 annual passive income

I believe these ASX 200 shares will continue rewarding passive income investors for years to come.

Read more »

Three businesspeople leap high with the CBD in the background.
Share Market News

Boom! ASX 200 blasts to new record highs

ASX 200 investors just sent the benchmark index into uncharted territory.

Read more »